(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases...
Stats | |
---|---|
今日成交量 | 3 820.00 |
平均成交量 | 25 968.00 |
市值 | 27.26M |
EPS | $-0.300 ( 2024-02-13 ) |
下一个收益日期 | ( $-0.350 ) 2024-06-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.510 |
ATR14 | $0.0430 (1.48%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-05 | Delaversano Robert J | Sell | 42 000 | Stock Options (Right to Buy) |
2023-12-19 | Kavuru Vimal | Buy | 10 000 | Stock Options (Right to Buy) |
2023-12-19 | Kottayil George | Buy | 22 500 | Stock Options (Right to Buy) |
2023-12-19 | Neugeboren Edward | Buy | 22 500 | Stock Options (Right to Buy) |
2023-12-19 | Davis A Brian | Buy | 22 500 | Stock Options (Right to Buy) |
INSIDER POWER |
---|
88.62 |
Last 64 transactions |
Buy: 4 252 386 | Sell: 2 858 533 |
Acasti Pharma Inc 财务报表
Annual | 2022 |
营收: | $0 |
毛利润: | $-52.16M (0.00 %) |
EPS: | $-5.71 |
FY | 2022 |
营收: | $0 |
毛利润: | $-52.16M (0.00 %) |
EPS: | $-5.71 |
FY | 2022 |
营收: | $0 |
毛利润: | $-15.59M (0.00 %) |
EPS: | $-0.270 |
FY | 2021 |
营收: | $196 000 |
毛利润: | $120 000 (61.22 %) |
EPS: | $-1.360 |
Financial Reports:
No articles found.
Acasti Pharma Inc
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。